Correlation Between NextCure and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both NextCure and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Immix Biopharma, you can compare the effects of market volatilities on NextCure and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Immix Biopharma.
Diversification Opportunities for NextCure and Immix Biopharma
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NextCure and Immix is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of NextCure i.e., NextCure and Immix Biopharma go up and down completely randomly.
Pair Corralation between NextCure and Immix Biopharma
Given the investment horizon of 90 days NextCure is expected to under-perform the Immix Biopharma. In addition to that, NextCure is 1.22 times more volatile than Immix Biopharma. It trades about -0.18 of its total potential returns per unit of risk. Immix Biopharma is currently generating about -0.07 per unit of volatility. If you would invest 218.00 in Immix Biopharma on October 22, 2024 and sell it today you would lose (14.00) from holding Immix Biopharma or give up 6.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NextCure vs. Immix Biopharma
Performance |
| Timeline |
| NextCure |
| Immix Biopharma |
NextCure and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NextCure and Immix Biopharma
The main advantage of trading using opposite NextCure and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |